Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | RAD51D |
| Variant | E233G |
| Impact List | missense |
| Protein Effect | unknown |
| Gene Variant Descriptions | RAD51D E233G lies within the ATPase domain of the Rad51d protein (PMID: 28646019). E233G results in homologous recombination-mediated DNA repair activity similar to wild-type Rad51d in cell culture (PMID: 28646019), but in another study, results in increased cell proliferation and telomere maintenance dysfunction in culture (PMID: 19033885), and has been demonstrated to confer resistance to cisplatin in cultured cells with decreased Tp53 expression (PMID: 19347880), and therefore, its effect on Rad51d protein function is unknown. |
| Associated Drug Resistance | |
| Category Variants Paths |
RAD51D mutant RAD51D E233G |
| Transcript | NM_002878.4 |
| gDNA | chr17:g.35103294T>C |
| cDNA | c.698A>G |
| Protein | p.E233G |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_002878 | chr17:g.35103294T>C | c.698A>G | p.E233G | RefSeq | GRCh38/hg38 |
| NM_002878.3 | chr17:g.35103294T>C | c.698A>G | p.E233G | RefSeq | GRCh38/hg38 |
| NM_002878.4 | chr17:g.35103294T>C | c.698A>G | p.E233G | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|